CASP1 and Alzheimer disease: Conversely, it has been shown that an NLRP3 deficiency can suppress brain caspase-1 and IL-1β activation, which remarkably inhibits amyloidosis and neuropathology, and ultimately enhances cognitive function in the AD mice model.